When the reaction crosses several systems at once.
Mast Cell Activation Syndrome involves the inappropriate release of mediators by immune cells present in virtually every tissue. The picture presents in more than one system simultaneously — and that simultaneity is what guides the investigation.
What it is
Mast cells are immune cells distributed across skin, digestive tract, vessels, lungs and nervous system. They carry mediators such as histamine, tryptase and prostaglandins, released in defensive situations. In MCAS this release occurs disproportionately and without a corresponding threat, producing symptoms across multiple systems.
Mast Cell Activation Syndrome
This list is informational and is not a self-diagnosis instrument. Isolated signs do not characterize the condition. Medical assessment considers the whole picture, its evolution and the applicable diagnostic criteria.
Skin
- Facial and neck flushing
- Itching without apparent cause
- Hives
- Dermographism
Digestive tract
- Abdominal pain
- Change in bowel habit
- Refractory reflux
- Nausea
Cardiovascular
- Palpitations
- Drops in blood pressure
- Near-syncope
Neurological
- Headache and migraine
- Altered concentration during episodes
- Sudden sensation of anxiety
Respiratory
- Persistent nasal congestion
- Throat-tightening sensation
- Wheezing
Situations that warrant investigation
Recurrent symptoms involving two or more systems simultaneously
Reactions to foods or medications with unremarkable allergy testing
Episodes triggered by heat, physical exertion, alcohol or stress
Coexistence with joint hypermobility or orthostatic intolerance
Current diagnostic criteria
The literature establishes three criteria that must be considered together. Medical assessment determines which apply to the case.
Typical, recurrent symptoms consistent with mediator release, involving two or more body systems.
Transient elevation of mediators during the symptomatic period. Serum tryptase is the most studied; urinary metabolites of histamine, prostaglandin D2 and leukotriene E4 may also be assessed.
Clinical response to medications acting on the production or action of these mediators, observed over follow-up.
How the investigation is conducted.
A defined path, with stages that build on one another. Each consultation begins where the previous one ended.
Listening and clinical timeline
Reconstructing the trajectory: when each symptom appeared, what preceded it, how it evolved and what has already been investigated. The order of events often points to the mechanism.
Integrating symptoms and systems
Joint analysis of skin, digestive tract, cardiovascular system, sleep and cognition. Symptoms treated as separate fragments rarely reveal what they share.
Hypotheses and targeted testing
Tests chosen from defined hypotheses, with attention to the correct moment of collection. In some conditions, the result depends on when the sample is taken.
Plan, follow-up and referrals
Reasoned direction, with follow-up of the response and, when the presentation calls for another specialty, the appropriate referral.
Criteria and limitations
Outside an episode, mediators tend to return to usual values — the timing of collection is decisive and cannot always be captured.
The presence of consistent symptoms does not establish the diagnosis. All three criteria must be assessed together, with exclusion of other causes.
Therapeutic response forms part of diagnostic reasoning and is assessed over follow-up, not in a single consultation.
Request information about the consultation
Briefly describe your case. The team will get in touch with guidance on the investigation and scheduling options.
This form does not perform clinical triage, does not establish a diagnosis and does not replace a medical consultation. Information is used solely for contact and scheduling guidance, under Brazilian data protection law (LGPD).
Frequently asked questions
Does MCAS show on allergy testing?
No. Conventional allergy tests assess IgE-mediated reactions to specific allergens. In MCAS, mediator release occurs through a different mechanism, which is why such tests are usually unremarkable while symptoms persist.
How long does the investigation take?
It depends on collecting mediators at an appropriate moment and correlating the complete picture. The first consultation defines hypotheses and a testing plan; reaching a conclusion usually requires follow-up with results in hand.
Is there a relationship with Ehlers-Danlos and orthostatic intolerance?
The literature describes frequent overlap between these conditions. Investigating one therefore actively considers the others.
Do I need a referral?
No referral is required. It helps to gather previous test results in chronological order and a record of symptoms and the situations that precede them.
Conditions investigated.
Ehlers-Danlos Syndrome
Connective tissue alterations with joint, cutaneous and systemic repercussions, assessed against current international criteria.
Long COVID
Symptoms persisting months after infection, with multisystem mechanisms under active investigation in the scientific literature.
Sleep Medicine
Assessment of sleep architecture and quality as a structural axis, frequently the element that reorganizes the understanding of a complex case.